Advancing CD38 from a marker of disease activity to an active regulator of interferon responses in juvenile dermatomyositis
Brittany Moser, Chioma J. Madubata, Marissa Y. Chou, Madison L. Lotstein, Zilan Zheng, Tushar Agashe, Ana Almonte-Loya, Taylor N. LaFlam, Aurora Rynda, Jennifer P. Fox, Jessica L. Turnier, Johann Gudjonsson, Joanne Michelle Kahlenberg, Gabriela K. Fragiadakis, Kanneboyina Nagaraju, , Jessica A Neely
This study identifies CD38 as a regulator of interferon responses in juvenile dermatomyositis and suggests its inhibition as a potential therapeutic strategy.
bioRxiv · Oct 20, 2026 · PreprintImmunology